Literature DB >> 3012941

The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine.

B B Fredholm, K Lindström.   

Abstract

The effect of two closely related xanthine derivatives, pentoxifylline and HWA 285, on cyclic AMP accumulation in rat hippocampal slices and on adenosine uptake in erythrocytes was examined. Pentoxifylline was a weak competitive antagonist of adenosine effects on cyclic AMP accumulation. HWA 285, by contrast, had a small stimulatory effect per se and also potentiated the effect of adenosine (10-30 microM). Neither pentoxifylline nor HWA 285 significantly affected the cyclic AMP accumulation induced by the stable adenosine analogue NECA or by alpha- or beta-adrenoceptor activation. HWA 285 was a much more potent inhibitor of adenosine uptake into human erythrocytes than pentoxifylline and other examined xanthines including thiocaffeine, 8-p-sulphophenyltheophylline, theophylline, caffeine and enprofylline. It is suggested that HWA 285 may potentiate, rather than antagonize, the effects of endogenous as well as exogenous adenosine, partly as a consequence of adenosine uptake inhibition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012941     DOI: 10.1111/j.1600-0773.1986.tb00093.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  11 in total

1.  Effects of an inhibitor of adenosine deaminase, deoxycoformycin, and of nucleoside transport, propentofylline, on post-ischemic recovery of adenine nucleotides in rat brain.

Authors:  J W Phillis; M H O'Regan
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

2.  Chronic effects of xanthines on levels of central receptors in mice.

Authors:  D Shi; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

3.  The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.

Authors:  C D Nicholson; S A Jackman; R Wilke
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

4.  Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia.

Authors:  P Andiné; K A Rudolphi; B B Fredholm; H Hagberg
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

5.  Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia.

Authors:  Valerie L Jacobs; Russell P Landry; Yingna Liu; Edgar Alfonso Romero-Sandoval; Joyce A De Leo
Journal:  Neuro Oncol       Date:  2011-11-15       Impact factor: 12.300

6.  Effect of ingested pentoxifylline on neutrophil superoxide anion production.

Authors:  S P Crouch; J Fletcher
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Effect of propentofylline on the biochemical lesion of the rat brain in aluminium-induced neurotoxicity.

Authors:  V Stefanovich; F Joó
Journal:  Metab Brain Dis       Date:  1990-03       Impact factor: 3.584

8.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004

9.  An adenosine uptake blocker, propentofylline, reduces glutamate release in gerbil hippocampus following transient forebrain ischemia.

Authors:  K Miyashita; T Nakajima; A Ishikawa; T Miyatake
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

10.  'Therapeutic window's for multiple drug treatment of experimental cerebral ischemia in gerbils.

Authors:  D B Stanimirovic; D V Micic; M Markovic; M Spatz; B B Mrsulja
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.